Leimen, Germany

Hartmut Voss

This inventor holds 3 USPTO granted patents. Top assignees: Europaisches Laboratorium Fur Molekularbiologie (Embl), Europasches Laboratorium Fur Molekularbiologie (Embl), Pharmacia Biotech Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hartmut Voss. Retrieved from https://idiyas.com/inventor/hartmut-voss-7yr8nn6x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 251(Granted Patents)


Location History:

  • Leimen, DE (1999)
  • Gaiberg, DE (1999)

Company Filing History:


Years Active: 1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hartmut Voss: Innovator in Nucleic Acid Sequencing

Introduction

Hartmut Voss is a notable inventor based in Leimen, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid sequencing. With a total of 3 patents to his name, Voss has established himself as a key figure in scientific innovation.

Latest Patents

Among his latest patents, Voss has developed methods for the simultaneous sequencing of nucleic acids. His work includes a patented method for sequencing nucleic acids, which has implications for various applications in genetics and biotechnology.

Career Highlights

Throughout his career, Hartmut Voss has worked with prominent organizations such as the European Molecular Biology Laboratory (EMBL) and Pharmacia Biotech Inc. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Voss has collaborated with esteemed colleagues in the field, including Wilhelm Ansorge and Scott Duthie. These partnerships have fostered innovation and have been instrumental in the development of new methodologies in nucleic acid research.

Conclusion

Hartmut Voss's contributions to nucleic acid sequencing and his collaborations with leading scientists highlight his importance in the field of molecular biology. His work continues to influence advancements in genetic research and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…